Ion Mobility Mass Spectrometry Imaging for Small Molecule Identification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current mass spectrometry imaging techniques face challenges in accurately identifying and localizing small molecules such as glycans, lipids, endogenous peptides, metabolites, and pharmaceuticals in thin tissue sections, as they rely heavily on fragment ion spectra which require substantial sample quantities and are insensitive due to mainly singly charged ions produced by MALDI ionization.

Innovation Solution

The method employs a mass spectrometer with an ion mobility separator to measure collisional cross sections and precise masses, using a second tissue sample for liquid chromatography and electrospray ionization to generate multiply charged ions, allowing for the identification and localization of small molecules by comparing retention times, collisional cross sections, and precise masses with a reference database.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If fragment ion spectra acquisition is used for substance identification, then identification accuracy is improved, but sample consumption increases and sensitivity decreases

Engineering Contradiction:
Improvesubstance identification accuracyVSAvoidsample consumption
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent changes the ionization parameters by using electrospray ionization (ESI) instead of matrix-assisted laser desorption ionization (MALDI). ESI produces multiply charged ions which enhance fragmentation efficiency and information content, allowing for better substance identification with smaller sample amounts. This parameter change resolves the contradiction by improving identification accuracy while reducing sample consumption.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces an intermediary step of extracting digest peptides from the tissue section and analyzing them by liquid chromatography-tandem mass spectrometry (LC-MS/MS). This intermediary process allows for accumulation of sufficient sample material and optimized fragmentation conditions, enabling accurate identification without directly consuming excessive sample during the imaging process.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If MALDI ionization is used, then ion production efficiency is improved, but ion charge state is limited to singly charged

Engineering Contradiction:
Improveion production efficiencyVSAvoidion charge state variety
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The patent changes the ionization method from MALDI to electrospray ionization (ESI). While ESI has lower ion production efficiency compared to MALDI, it produces multiply charged ions (parameter change in charge state), which provides greater versatility for analyzing different molecular weights and enables more informative fragmentation patterns for substance identification.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If two tissue sections are used for identification, then substance identification reliability is improved, but sample requirement increases

Engineering Contradiction:
Improveidentification reliabilityVSAvoidtissue sample requirement
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent extracts digest peptides from the tissue section for separate LC-MS/MS analysis. By taking out the peptides from the tissue matrix, the method allows one tissue section to serve dual purposes: maintaining spatial information for imaging while providing extracted material for reliable identification through tandem mass spectrometry with fragment ion spectra.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the accurate identification and localization of small molecules in thin tissue sections by combining precise mass and ion mobility data, improving the sensitivity and specificity of substance identification beyond what is possible with fragment ion spectra alone.

Implementation Method 1

separating the ions according to their ion mobility and measuring corresponding ion mobility values

Methodology Applied
Scientific EffectIon mobility separation:

Implementation Method 2

measuring a mass spectral image with ion mass and ion mobility maps per pixel

Methodology Applied
Scientific EffectMass spectrometry:

Implementation Method 3

electrospray ionization to generate multiply charged ions

Methodology Applied
Scientific EffectElectrospray ionization:

Implementation Method 4

separating the small molecules and analyzing the small molecules by liquid chromatography with tandem mass spectrometry

Methodology Applied
Scientific EffectLiquid chromatography: Chromatography

Data Source

PatentUS11854778B2Mass spectrometry imaging with substance identification using ion mobility
Publication Date: 2023.12.26 BRUKER SCIENTIFIC LLC
  • US11854778B2 patent drawing
  • US11854778B2 patent drawing

AI summary

A method for the identification and localization of small molecule species in a histologic thin tissue section comprises the steps of: a) acquiring a mass/mobility image of the tissue section and generating a mass/mobility map of the small molecule species of interest for each pixel of the image; b) providing a second sample of the same tissue and extracting the small molecules of interest, separating them, and acquiring mass and ion mobility spectra from the separated small molecules; c) identifying the small molecules of interest using corresponding reference databases; and d) assigning identified small molecules to entries in the mass/mobility maps of the first tissue section by comparison of ion masses and mobilities of the identified species to those of the second thin tissue section.